European stocks weakened Thursday, as worries over the impact of rise in coronavirus cases on economic growth took the shine off the optimism over progress on a potential vaccine.
The U.S. coronavirus situation is worsening, with the country setting another record for confirmed cases on Wednesday. Christophe Barraud, chief economist and strategist at Market Securities in Paris and a multiple winner of MarketWatch’s forecasting contest, pointed out that small-business data that’s available data is showing a discrepancy in U.S. activity between northern states in cooler climates and southern states in warmer climates.
He expects more states to join New Jersey and Wisconsin in implementing new restrictions, as hospitalizations are due to spike given the relationship to cases. “Therefore, in a context where the economic recovery has already lost momentum, upcoming drastic restrictions will probably result in another GDP contraction as soon as the fourth quarter,” he said.
After lockdowns across Europe, the case growth on the Continent has dropped but is still elevated, according to data from the European Centre for Disease Prevention and Control. Data from the U.K. showed that GDP recovered by a slightly below-forecast 15.5% in the third quarter, and by 1.1% in September. Samuel Tombs, chief U.K. economist at Pantheon Macroeconomics, said GDP probably was no higher in October than in September and will plummet in November due to the new lockdowns.
Of stocks on the move, German conglomerate Siemens SIE,
Legal & General LGEN,
Burberry Group BRBY,